Form D · Biotechnology

CBA PHARMA INC

Lexington, KY · CIK 0001143410

Offering snapshot reported Jan 30, 2015 · SEC filing

Reported sold
$100K
Offering amount: $20M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 20, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 30, 2015Initial$100,000No comparison1SEC filing
Jun 6, 2013Amendment$5,300,486$4,761,361vs Feb 28, 2012136SEC filing
Feb 28, 2012Initial$539,125No comparison41SEC filing
Apr 2, 2010Amendment$3,928,115$3,803,115vs Mar 25, 2009149SEC filing
Mar 25, 2009Initial$125,000No comparisonNot reportedSEC filing
Jun 20, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-233209

Source: Form D, filed Jan 30, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Louis Carmichael Executive
Robert P. Granacher, Jr., Md, Mba Director
Beth Diane Gudeman Director, Executive, Promoter
George P. Julius, Jr. Director, Executive
Shelden Le Bron Executive
Lawrence S. Martini Executive
Scott Mc Kinney Director, Executive
Robert K. Oldham, Md Executive
W. Michael Putnam Director, Executive, Promoter
Stephen Whitman Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
670 Perimeter Dr
Lexington, KY, 40517